Neumentum is dedicated to becoming a leading non-opioid analgesic and neurology specialty pharmaceutical company with 6 novel non-opioid products in development to treat pain, both in the U.S. and around the world. The Company aims to address shortfalls of current pain management treatments by developing and commercializing effective and safe, non-opioid options without the risks of abuse, misuse, and diversion seen with opioids, or the opioid-induced side effects, including potentially life-threatening respiratory depression.

Biotechnology

Health Care

Life Sciences

Pharmaceutical

Neumentum

Joseph V. Pergolizzi

Joseph M. Scavone

Mark Kociscin

Frank Diana

Robert B. Raffa

Advisory Team

Leadership Team

Neumentum

Org chart

Teams

Advisory Team

Leadership Team

Similar companies